UBS Group’s Bruker BRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.3M | Sell |
809,896
-190,571
| -19% | -$7.97M | ﹤0.01% | 2193 |
|
|
2025
Q4 | $47.1M | Sell |
1,000,467
-413,452
| -29% | -$17.5M | 0.01% | 1685 |
|
|
2025
Q3 | $45.9M | Buy |
1,413,919
+936,820
| +196% | +$33.4M | 0.01% | 1714 |
|
|
2025
Q2 | $19.7M | Sell |
477,099
-96,863
| -17% | -$3.74M | ﹤0.01% | 2374 |
|
|
2025
Q1 | $24M | Buy |
573,962
+326,361
| +132% | +$17M | ﹤0.01% | 2157 |
|
|
2024
Q4 | $14.5M | Sell |
247,601
-71,497
| -22% | -$4.23M | ﹤0.01% | 2674 |
|
|
2024
Q3 | $22M | Buy |
319,098
+37,044
| +13% | +$2.39M | ﹤0.01% | 1744 |
|
|
2024
Q2 | $18M | Buy |
282,054
+170,864
| +154% | +$12.9M | ﹤0.01% | 1777 |
|
|
2024
Q1 | $10.4M | Buy |
111,190
+81,448
| +274% | +$6.55M | ﹤0.01% | 2233 |
|
|
2023
Q4 | $2.19M | Buy |
29,742
+3,756
| +14% | +$241K | ﹤0.01% | 3725 |
|
|
2023
Q3 | $1.62M | Sell |
25,986
-1,254
| -5% | -$84.4K | ﹤0.01% | 3649 |
|
|
2023
Q2 | $2.01M | Sell |
27,240
-29,795
| -52% | -$2.27M | ﹤0.01% | 3517 |
|
|
2023
Q1 | $4.5M | Sell |
57,035
-14,608
| -20% | -$1.05M | ﹤0.01% | 2612 |
|
|
2022
Q4 | $4.9M | Buy |
71,643
+51,378
| +254% | +$3.26M | ﹤0.01% | 2522 |
|
|
2022
Q3 | $1.07M | Sell |
20,265
-623
| -3% | -$37.2K | ﹤0.01% | 3694 |
|
|
2022
Q2 | $1.31M | Sell |
20,888
-611
| -3% | -$37.5K | ﹤0.01% | 3495 |
|
|
2022
Q1 | $1.38M | Sell |
21,499
-60,222
| -74% | -$4.12M | ﹤0.01% | 3785 |
|
|
2021
Q4 | $6.86M | Buy |
81,721
+38,359
| +88% | +$3.07M | ﹤0.01% | 2500 |
|
|
2021
Q3 | $3.39M | Buy |
43,362
+16,382
| +61% | +$1.36M | ﹤0.01% | 3102 |
|
|
2021
Q2 | $2.05M | Sell |
26,980
-42,328
| -61% | -$2.96M | ﹤0.01% | 3561 |
|
|
2021
Q1 | $4.46M | Buy |
69,308
+1,972
| +3% | +$118K | ﹤0.01% | 2736 |
|
|
2020
Q4 | $3.65M | Buy |
67,336
+17,920
| +36% | +$859K | ﹤0.01% | 2780 |
|
|
2020
Q3 | $1.96M | Sell |
49,416
-1,808
| -4% | -$75.4K | ﹤0.01% | 3061 |
|
|
2020
Q2 | $2.08M | Sell |
51,224
-23,613
| -32% | -$929K | ﹤0.01% | 2836 |
|
|
2020
Q1 | $2.68M | Sell |
74,837
-36,098
| -33% | -$1.67M | ﹤0.01% | 2476 |
|
|
2019
Q4 | $5.65M | Buy |
110,935
+38,682
| +54% | +$1.84M | ﹤0.01% | 2500 |
|
|
2019
Q3 | $3.17M | Sell |
72,253
-94,862
| -57% | -$4.25M | ﹤0.01% | 2829 |
|
|
2019
Q2 | $8.35M | Buy |
167,115
+143,669
| +613% | +$6.05M | ﹤0.01% | 1910 |
|
|
2019
Q1 | $901K | Sell |
23,446
-23,571
| -50% | -$851K | ﹤0.01% | 3667 |
|
|
2018
Q4 | $1.4M | Buy |
47,017
+21,392
| +83% | +$675K | ﹤0.01% | 3384 |
|
|
2018
Q3 | $857K | Sell |
25,625
-17,721
| -41% | -$584K | ﹤0.01% | 3986 |
|
|
2018
Q2 | $1.26M | Buy |
43,346
+566
| +1% | +$17.2K | ﹤0.01% | 3584 |
|
|
2018
Q1 | $1.28M | Sell |
42,780
-156
| -0.4% | -$5.06K | ﹤0.01% | 3525 |
|
|
2017
Q4 | $1.47M | Sell |
42,936
-16,930
| -28% | -$555K | ﹤0.01% | 3453 |
|
|
2017
Q3 | $1.78M | Buy |
59,866
+8,871
| +17% | +$255K | ﹤0.01% | 3224 |
|
|
2017
Q2 | $1.47M | Sell |
50,995
-9,083
| -15% | -$234K | ﹤0.01% | 3284 |
|
|
2017
Q1 | $1.4M | Sell |
60,078
-12,705
| -17% | -$298K | ﹤0.01% | 3250 |
|
|
2016
Q4 | $1.54M | Buy |
72,783
+15,550
| +27% | +$340K | ﹤0.01% | 3148 |
|
|
2016
Q3 | $1.3M | Sell |
57,233
-26,943
| -32% | -$617K | ﹤0.01% | 3226 |
|
|
2016
Q2 | $1.91M | Buy |
84,176
+7,674
| +10% | +$205K | ﹤0.01% | 2806 |
|
|
2016
Q1 | $2.14M | Buy |
76,502
+6,967
| +10% | +$174K | ﹤0.01% | 2605 |
|
|
2015
Q4 | $1.69M | Buy |
69,535
+16,058
| +30% | +$333K | ﹤0.01% | 2956 |
|
|
2015
Q3 | $878K | Buy |
53,477
+4,086
| +8% | +$79.4K | ﹤0.01% | 3467 |
|
|
2015
Q2 | $1.01M | Sell |
49,391
-974
| -2% | -$19.7K | ﹤0.01% | 3564 |
|
|
2015
Q1 | $930K | Sell |
50,365
-44,795
| -47% | -$849K | ﹤0.01% | 3637 |
|
|
2014
Q4 | $1.87M | Buy |
+95,160
| New | +$1.83M | ﹤0.01% | 2969 |
|
Other funds holding BRKR
OAG
PCA
VPM
VCM
EDRH
SC
UBS Group's BRKR Position: Q1 2026 in Review
UBS Group reduced its Bruker (BRKR) stake by 19% in Q1 2026, selling an estimated $7.97M and leaving 809,896 shares worth $29.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2193.
UBS Group first reported a position in BRKR in Q4 2014 and has held it in 46 quarters since. The position peaked at $47.1M in Q4 2025. 343 funds tracked by Wall St. Rank hold BRKR as of Q1 2026.
- UBS Group held 809,896 shares of Bruker worth $29.3M as of Q1 2026.
- UBS Group sold 190,571 Bruker shares in Q1 2026, an estimated $7.97M.
- Bruker made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2193 holding.
- UBS Group first reported a position in Bruker in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Bruker position peaked at $47.1M in Q4 2025.
- 343 funds tracked by Wall St. Rank held Bruker as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.